Inhibition of leucocyte elastase by heparin and its derivatives

125Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Leucocyte proteinases, e.g. leucocyte elastase and cathepsin G, are inhibited by heparin. The activities of pig pancreatic and Pseudomonas aeruginosa elastases are unaffected by this polysaccharide. Heparin derivatives of known M(r) and degree of sulphation were isolated. The inhibition of leucocyte elastase by these oligosaccharides can be classified as tight-binding hyperbolic non-competitive. K(i) values ranged from 40 nM to 100 μM and were found to be inversely correlated with the chain length of the oligosaccharides. Desulphated compounds lacked inhibitory potential towards leucocyte elastase. Over-O-sulphated di- and tetra-saccharides are more potent inhibitors than their over-N-sulphated counterparts. It is proposed that the therapeutic use of heparin and its derivatives could be extended to disease states such as emphysema and rheumatoid arthritis, where the role of leucocyte elastase has been clearly established.

Cite

CITATION STYLE

APA

Redini, F., Tixier, J. M., Petitou, M., Choay, J., Robert, L., & Hornebeck, W. (1988). Inhibition of leucocyte elastase by heparin and its derivatives. Biochemical Journal, 252(2), 515–519. https://doi.org/10.1042/bj2520515

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free